ÃÞ»¨ÌÇÖ±²¥

1. Abstract Title: Please use a short and concise title that indicates the content of the abstract. (Note: the title is not included in the total character count of 2,200).
2. Presenting Author: The abstract submitter must be the presenting author. The presenting author may submit up to 2 abstracts. You cannot submit an abstract on another author’s behalf.
3. Required Author(s) Information: Include the author(s)'s name(s), institution(s), location(s), title(s).
4. Identify Track: For purposes of review and programming, abstracts are divided into Tracks. Selection of the most appropriate Track is important, as it determines who reviews your abstract. The ÃÞ»¨ÌÇÖ±²¥ CVS Program Committee reserves the right to reassign your abstract to a more appropriate Track.
5. Abstract Body Text: Your abstract may have up to 2,200 characters, which does not include title, authors, groups and affiliations. Tables and graphics (maximum of 500 characters) are included in the character count. Spaces are not counted. Do not include abstract title, authors or keywords in abstract text. Abstract text may be submitted using either of the following methods: Copy/paste, direct entry keystrokes or file upload. Your abstract may be written without the use of the following bolded headers: Background, Methods, Results, Conclusion. However, follow the abstract guidelines to ensure all required information about your study is provided in your abstract.

For detailed information and step-by-step instructions on how to submit your abstract, please . 

If you need technical support and have any questions regarding use of the abstract submission site, please contact technical support.

Dispositions

Abstract disposition notices will be issued via email notification to presenting authors on the following dates: 

• Early Abstract Submissions: April 30, 2024.
• General Abstract, Travel Awards and Case Study Submissions: July 9, 2024.
• Late-Breaker Submissions: Aug. 22, 2024.

It is the responsibility of the presenting author to inform all co-authors of disposition status and accepted abstract scheduling information.

Presentation Dates

There will be 2 Poster Sessions at the 2024 ÃÞ»¨ÌÇÖ±²¥ Clinical Virology Symposium on Tuesday, Oct. 8 and Wednesday, Oct. 9. Posters will be displayed between 10 a.m.–6:30 p.m. ET daily. Presenting authors are required to be available at their assigned poster board between 4:30–6:30 p.m. ET.

Withdrawals and Penalties

Individuals who submit abstracts should consider them official communication to the symposia. If an abstract must be withdrawn, the author must send a letter of explanation to ÃÞ»¨ÌÇÖ±²¥ at clinicalvirology@asmusa.org. If an accepted abstract is published prior to 2024 ÃÞ»¨ÌÇÖ±²¥ Clinical Virology Symposium, the authors must agree to withdraw the abstract. Withdrawals of abstracts made after Aug. 1, 2024, may be subject to a penalty, prohibiting the author from presenting papers at ÃÞ»¨ÌÇÖ±²¥ meetings and conferences for up to 3 years. A letter will be emailed to individuals subject to this penalty. Those who wish to dispute the penalty must notify the ÃÞ»¨ÌÇÖ±²¥ Clinical Virology Symposium Program Committee in writing and send it to the attention of the ÃÞ»¨ÌÇÖ±²¥ Programming Team. A response letter will be emailed to the presenting author once the committee has considered and acted on your exception request.